|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia显示文摘 | TSIMBERIDOU A M KANTARJIAN H W WEN S | 2008 | Cancer2008，113，： | 1 |
| 2 | Immunosuppression and infectious complications in patients with stage Ⅳ indolent lymphoma treated with a fludarabine, mitoxantrone, and dexaethasone regimen显示文摘 | Tsimberidou AM Younes A Romaguera J | 2005 | Cancer2005，104，2： | 1 |
| 3 | Activity of interferon - alpha and isotretionoin in patients with advanced, refractor lymphoid malignancies 显示文摘 | TSIMBERIDOU A M GILES F ROMAGUERA J | 2004 | Cancer2004，100，4： | 1 |
| 4 | Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage Ⅳ indolent lymphoma 显示文摘 | Tsimberidou AM Mclaughlin P Younes A | 2002 | Blood2002，100，： | 1 |
| 5 | Gemtuzumab ozo- gamicin,fludarabine, cytarabine and cyclosporine combina- tion regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia 显示文摘 | Tsimberidou A Cortes J Thomas D | 2003 | Leuk Res2003，27，10： | 1 |
| 6 | Dasatinib in chronic myeloid leukemia: a review显示文摘 | Aguilera D G Tsimberidou A M | 2009 | Ther Clin Risk Manag2009，5，： | 1 |
| 7 | Extramedullary relapse in a patient with acute promyelocytic leukemia:successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies显示文摘 | TSIMBERIDOU A M ESTEY E WHITMAN G J | 2004 | Leuk Res2004，28，： | 1 |
| 8 | Gemtuzumab ozogamiein, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD+33 primary resistant or re lapsed acute myeloid leukemia 显示文摘 | Tsimberidou A Cortes J Thomas D | 2003 | Leuk Res2003，27，10： | 1 |
| 9 | TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies显示文摘 | TSIMBERIDOU A M GILES F J | 2002 | Expert Rev Anticancer Ther2002，2，3： | 1 |
| 10 | Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy:the example of liposomal all-trans retinoic acid显示文摘 | Estey E Koller C Tsimberidou A M | 2005 | Blood2005，105，3： | 1 |
| 11 | Phase I Clinical Trials in 93 Patients with Brain Metastases: The M. D. Anderson Cancer Center Experience显示文摘 | Tsimberidou AM Letourneau K Wen S Wheler JJ Hong DS Naing A Iskander NG Uehara C Kurzrock R | 2011 | 中国神经肿瘤杂志2011，9，1： | 1 |
| 12 | BRAF mutations in advanced cancers: clinical characteristics and outcomes 显示文摘 | EI-Osta H Falchook G Tsimberidou A | 2011 | PLoS One2011，6，25： | 1 |
| 13 | PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitor 显示文摘 | Janku F Tsimberidou A M Garrido-Laguna I | 2011 | Mol Cancer Ther2011，10，3： | 1 |
| 14 | Phase Ⅱ study of fludarabine,cytarabine (Ara-C),cyclophosphamide,cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders显示文摘 | Tsimberidou A M O'Brien S M Cortes J E | 2002 | Leuk Lymphoma2002，43，4： | 1 |
| 15 | Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis显示文摘 | Shim S Stemke-Hale K Tsimberidou A M | 2013 | Biomicrofluidics2013，7，11： | 1 |
| 16 | Gemtuzumab ozogamiein,fludarabine,cvtarabine and cyelosporine combination regimenin patients with CD33^+ fiprimary resistant or relapsed acute myeloid leukemia显示文摘 | Tsimberidou A Cortes J Thomas D | 2003 | Leuk Res2003，27，10： | 1 |
| 17 | Pilot study of Mylotarg,idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia显示文摘 | Alvarado Y Tsimberidou A Kantarjian H | 2003 | Cancer Chemother Pharmacol2003，51，1： | 1 |
| 18 | Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33 primary resistant or relapsed acute myeloid leukemia 显示文摘 | Tsimberidou A Cortes J Thomas D | 2003 | Leuk Res2003，27，10： | 1 |
| 19 | Lenalidomide in solid tumors显示文摘 | Segler A Tsimberidou AM | 2012 | Cancer Chemother Pharmacol2012，69，6： | 1 |
| 20 | Pilot study of Mylotarg, idarubiein and eytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia 显示文摘 | Alvarado Y Tsimberidou A Kantarjian H | 2003 | Cancer Chemother Pharmacol2003，51，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员